Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sandoz launches intravenous medicine generic Ferumoxytol for iron deficiency anemia

Ruchika Sharma20 July 2021 9:30 AM IST

Princeton: Sandoz has recently announced the immediate US availability of generic Ferumoxytol, an intravenous medicine used to treat iron deficiency...

BioNTech to buy Kite Gaithersburg manufacturing facility, Neoantigen TCR cell therapy RnD platform

Ruchika Sharma20 July 2021 9:00 AM IST

Germany: BioNTech SE and Kite, a Gilead Company have recently announced that the two companies have entered into a purchase agreement...

Johnson and Johnson exploring putting talc liabilities into bankruptcy: Report

Ruchika Sharma19 July 2021 3:30 PM IST

New Delhi: Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that...

AstraZeneca small cell lung cancer treatment Imfinzi gets nod in China

Ruchika Sharma19 July 2021 2:15 PM IST

UK: Pharma major, AstraZeneca, announced that Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with...

Healthcare to have special focus in coming decades: Cadila Healthcare

Ruchika Sharma19 July 2021 1:00 PM IST

New Delhi: Healthcare will see a special focus in the coming decades to tackle unforeseen situations like COVID-19 or bridge unmet needs, and Zydus is...

Prosecution launched against Gautam Gambhir Foundation, 2 AAP MLAs in covid drugs case: Delhi Drugs Control Dept tells court

Ruchika Sharma19 July 2021 11:30 AM IST

The counsel for drug controller said that show cause notices have been issued to licensees under the Drugs and Cosmetics Act as well as those who were...

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

Aiming for self sufficiency in Medical Devices, Kerala to set up Medical Equipment and Devices Park

Ruchika Sharma19 July 2021 10:00 AM IST

Health Minister Veena George, who called for self sufficiency in medical production, said Kerala was importing 90 percent of its required medicines...

Pfizer to pay over Rs 2574 crore to resolve EpiPen pricing lawsuit

Ruchika Sharma18 July 2021 12:00 PM IST

New Delhi: Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who say they overpaid for EpiPens due to anticompetitive...

Merck gets USFDA nod for Pneumococcal 15-valent Conjugate Vaccine

Ruchika Sharma18 July 2021 10:30 AM IST

Kenilworth: Merck known as MSD outside the United States and Canada, has recently announced the U.S. Food and Drug Administration (USFDA) approved...

Pfizer-BioNTech COVID vaccine to be reviewed by USFDA by January

Ruchika Sharma18 July 2021 10:00 AM IST

New Delhi: The U.S. health regulator will review Pfizer and German partner BioNTech SE's application for full approval of their COVID-19...

COVID vaccine vial maker Stevanato raises USD 672 million in US IPO

Ruchika Sharma18 July 2021 9:30 AM IST

New York: Stevanato Group S.p.A., an Italian maker of glass vials for COVID-19 vaccines and other healthcare products, raised $672 million in a...

Covid-19: JnJ, Pfizer yet to apply for license of vaccines in India

Ruchika Sharma18 July 2021 9:15 AM IST

New Delhi: The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok